Fibrin sealant delivery method
US5219328A · kind A · utility
212Cited by
16References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 1990 |
| Grant date | Jun 15, 1993 |
| Priority date | — |
| Expiry date | Jan 3, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2017/22082
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention relates to a method for the formulation of fibrin sealant in a single delivery system. The method involves mixing a fibrinogen/Factor XIII precipitate solution with thrombin under conditions such that thrombin clotting activity is inhibited and said mixture is applied to a body site under conditions which activate the thrombin to convert fibrinogen into fibrin sealant. A single device, syringe or container, can be used to apply the fibrin sealant formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.